Search

Your search keyword '"Pai, Lee-Yuh"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Pai, Lee-Yuh" Remove constraint Author: "Pai, Lee-Yuh"
35 results on '"Pai, Lee-Yuh"'

Search Results

1. Discovery of MK-8153, a Potent and Selective ROMK Inhibitor and Novel Diuretic/Natriuretic

2. Soluble guanylate cyclase stimulators for the treatment of hypertension: Discovery of MK-2947

3. Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophores

4. The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diuretics

5. Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold

6. Differentiation of ROMK potency from hERG potency in the phenacetyl piperazine series through heterocycle incorporation

7. Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-one

9. Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure

10. Discovery of Triazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys

11. Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation

12. Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys

15. Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors

16. Pharmacologic Inhibition of the Renal Outer Medullary Potassium Channel Causes Diuresis and Natriuresis in the Absence of Kaliuresis

17. The correlation of pharmacodynamic activity of mineralocorticoid receptor antagonism with its blood pressure lowering effect in rat with the remnant kidney

18. Discovery of a Highly Potent, Selective, and Bioavailable Soluble Epoxide Hydrolase Inhibitor with Excellent Ex Vivo Target Engagement

20. Estrogen receptor ligands. Part 14: Application of novel antagonist side chains to existing platforms

21. Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain

24. Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs

26. Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers

27. Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains

28. Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains

31. Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators

32. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II Phenotype.

33. Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresis.

34. Estrogen receptor-beta regulates tryptophan hydroxylase-1 expression in the murine midbrain raphe.

35. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.

Catalog

Books, media, physical & digital resources